- CRS Publications
- News
News
Authors:
Date:
Andi Dian Permana1, Alejandro J. Paredes2, Fabiana Volpe-Zanutto2,3, Muh. Nur Amir4, Ismail Ismail5, Muh. Akbar Bahar4, Sumarheni6, Santiago Daniel Palma7, Ryan F. Donnelly2*…
Date:
This article summarizes selected patents in the area of controlled release or delivery that were issued from December 14, 2021 through April 12, 2022. Greater detail on each of these patents is given on the U.S. patent website https://patft.uspto.gov.…
Date:
The Agilent 708-DS Dissolution Apparatus and Agilent 850-DS Dissolution Sampling Station are two of the most popular solutions available for your dissolution testing requirements.
With so many of these instruments in use across the world, we often get questions regarding parts, setup, and general…
Date:
This article summarizes selected patents in the area of controlled release or delivery that were issued from August 31, 2021 through December 7, 2021. Greater detail on each of these patents is given on the U.S. patent website https://patft.uspto.gov.…
Date:
Members of the Women in Science executive board met in December to plan 2022 activities. From top to bottom, left to right: Maria Jose Alonso, Andrea Joseph, Sujuan Ba, Ruth Schmid, Sara Cordeiro, Renata F. V. Lopez, Nidhi Raval, Danchen Gao, and Ana Cadete.…
Date:
Business Wire: August 7, 2017 – JERUSALEM, Israel – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved QVAR® RediHaler™ (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the…